| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $22.6M | +16.5% | +53.4% |
| Cost of Revenue | $11.1M | +5.9% | +25.5% |
| Gross Profit | $11.4M | +29.1% | +96.0% |
| R&D Expense | $4.9M | +21.9% | +39.0% |
| SG&A Expense | $38.3M | +13.6% | +78.5% |
| Operating Income | -$31.8M | -10.0% | -66.0% |
| Pre-tax Income | -$32.8M | -27.0% | -58.9% |
| Income Tax | $34K | +3.0% | +325.0% |
| Net Income | -$32.8M | -26.9% | -61.0% |
| EPS (Basic) | -$0.64 | -28.0% | +46.2% |
| EPS (Diluted) | -$0.64 | -28.0% | +46.2% |
| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $175.4M | -12.8% | +128.1% |
| Accounts Receivable | $10.4M | +12.6% | — |
| Current Assets | $195.4M | -11.5% | — |
| Total Assets | $246.7M | -7.4% | — |
| Current Liabilities | $35.8M | +10.9% | — |
| Long-term Debt | $41.9M | +0.9% |
| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$44.6M | -69.8% | — |
| Capital Expenditures | $15.4M | +89.0% | — |
| Investing Cash Flow | -$15.7M | -90.1% | — |
| Financing Cash Flow | -$1.9M | -1.4% | — |
| Free Cash Flow | -$60.0M | -74.4% | — |
| — |
| Total Liabilities | $82.6M | +0.6% | — |
| Stockholders' Equity | $164.1M | -10.9% | +169.4% |